3SBio

3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing.

Launch date

1993

Employees

Market cap

Enterprise valuation

€1.3b (Public information from Sep 2024)

Shenyang Liaoning (HQ)

http://www.3sbio.com/en/

https://www.linkedin.com/company/3sbio-inc./

Revenues, earnings & profits over time

CNY	2020	2021	2022	2023	2024	2025	2026
Revenues	5.6b	6.4b	6.9b	7.8b	8.9b	9.7b	10.6b
% growth	5 %	14 %	7 %	14 %	14 %	9 %	10 %
EBITDA	1.6b	2.3b	2.8b	2.8b	3.1b	3.4b	3.7b
% EBITDA margin	29 %	36 %	40 %	36 %	35 %	35 %	34 %
Profit	836m	1.7b	1.9b	1.5b	2.0b	2.3b	2.5b
% profit margin	15 %	26 %	28 %	20 %	23 %	23 %	23 %
EV / revenue	2.7x	2.1x	3.0x	2.4x	1.4x	1.1x	0.7x
EV / EBITDA	9.4x	5.7x	7.3x	6.5x	4.0x	3.0x	2.0x
R&D budget	590m	754m	693m	795m	-	-	-
R&D % of revenue	11 %	12 %	10 %	10 %	-	-	-

Source: Dealroom estimates

Date	Investors	Amount	Round
Feb 2007	N/A	N/A	IPO
Jun 2015	N/A	N/A	IPO
Total Funding		-

Tech stackLearn more about the technologies and tools that this company uses.

GenSight Biologics

exited

exited

Refuge Biotechnologies

Therapure Biopharma

ACQUISITION by 3SBio Sep 2017

Verseau Therapeutics

Allorion Therapeutics